Day One Biopharmaceuticals Inc (DAWN) earnings · rev $131.2M
Day One Biopharmaceuticals Inc (DAWN) is a biotechnology company listed on US.
This DAWN earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported DAWN revenue for 2024-12-31 was $131.2M. Net income was -$95.5M. DAWN currently screens at market cap $656.8M.
When the next DAWN 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
Period-over-period revenue change is not in cache for DAWN. We will not invent a beat or miss.
Not investment advice. Full DAWN research stays on the stock page; the tape stays on the quote page.
Not investment advice.